SC
VBIV

Steven Cohen’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Steven Cohen’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,347
Closed -$312K – 1358
2021
Q3 		$312K Buy
+3,347
New +$318K ﹤0.01% 948

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Steven Cohen's VBIV Position: Q4 2021 in Review

Steven Cohen sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q4 2021, closing a stake of 3,347 shares — an estimated $312K sold.

Steven Cohen first reported a position in VBIV in Q3 2021 and held it in 1 quarter. The position peaked at $312K in Q3 2021. 134 funds tracked by Wall St. Rank hold VBIV as of Q4 2021.

  • Steven Cohen reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q4 2021 after selling out during the quarter.
  • Steven Cohen sold 3,347 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q4 2021, an estimated $312K.
  • Steven Cohen first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 1 quarter.
  • Steven Cohen's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $312K in Q3 2021.
  • 134 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q4 2021.

Based on Point72 Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.